Anhui Shi, MD
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC) (NCT07050472) | Anhui Shi, MD | 2025-08-11 |
| Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001) (NCT06719336) | Anhui Shi, MD | 2024-12-16 |
| Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029） (NCT03743129) | Anhui Shi, MD | 2019-04-12 |
Track Anhui Shi, MD automatically
Every clearance here is in the API, with alerts when new ones post.